Salicylic acid

Description

No relevant information is available to construct a Description section for the specified SPL code 34089-3.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, “cauliflower-like” surface appearance, while plantar warts are specifically located on the bottom of the foot, presenting with tenderness and an interruption of the footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The drug should be administered as prescribed by the healthcare provider. Dosage may vary based on the patient's condition and response to treatment; therefore, it is essential to follow the specific dosage instructions provided in the prescribing information.

Administration of the drug must occur via the specified route as indicated in the prescribing information. The frequency of administration should adhere to the guidelines provided by the healthcare provider or as specified in the prescribing information.

Contraindications

Use is contraindicated in patients with diabetes or poor blood circulation due to the potential for exacerbating these conditions. Additionally, the product should not be swallowed; in the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is required.

Warnings and Precautions

For external use only, this product must be applied solely to the affected area. It is imperative to keep the product away from fire and flame to prevent any hazardous incidents.

General precautions should be observed to ensure safe usage. Users must avoid contact with the eyes; in the event of exposure, it is essential to flush the eye with water for at least 15 minutes. Inhalation of vapors should also be avoided to minimize respiratory irritation. The bottle should be capped tightly after each use to maintain product integrity. Additionally, the product should be stored out of direct sunlight and at room temperature, away from heat sources.

Patients are advised to discontinue use and consult a healthcare professional if discomfort persists. Special caution is warranted for individuals with diabetes or poor blood circulation, as they may be at increased risk for adverse effects. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Emergency medical help should be obtained without delay if the product is swallowed. Prompt action is crucial in such situations to ensure safety and appropriate care.

Side Effects

Patients should be aware that the product is for external use only and must be applied solely to the affected area. It is crucial to keep the product away from fire and flame to prevent any potential hazards.

In the event that discomfort persists after application, patients are advised to stop use and consult a healthcare professional. Special caution is warranted for individuals with diabetes or poor blood circulation, as these conditions may increase the risk of adverse reactions.

Additionally, the product should be kept out of reach of children. In the case of accidental ingestion, it is imperative to seek medical assistance immediately or contact a Poison Control Center for guidance.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Wart Remover. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep the medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while on this medication.

Lactation

The safety of this product during lactation has not been established. There is a potential for excretion in breast milk; therefore, caution should be exercised when administering this product to nursing mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted in these patients to ensure their safety during treatment.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical assistance or contact a Poison Control Center without delay.

Prompt action is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action and management strategies.

Healthcare providers should ensure that patients are aware of the importance of timely reporting of any overdosage incidents to facilitate effective treatment and minimize risks.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. Patients should be informed to avoid contact with the eyes; in the event of contact, they should flush the eye with water for 15 minutes. It is also important to instruct patients to avoid inhaling vapors from the product.

Patients should be reminded to securely cap the bottle after use and to store the product in a cool, dry place, away from direct sunlight and heat, ideally at room temperature.

Healthcare providers should counsel patients to discontinue use and seek medical advice if discomfort persists, if they have diabetes, or if they experience poor blood circulation. In the case of accidental ingestion, patients should be instructed to seek medical help or contact a Poison Control Center immediately.

Storage and Handling

The product is supplied in a container that must be capped tightly to maintain its integrity. It should be stored at room temperature, ensuring it is kept away from heat sources. Additionally, it is important to protect the product from direct sunlight to preserve its quality.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Wart Remover, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)